1. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course
- Author
-
Yves Moene, Pierric Giraud, Guy Chazot, Olivier Joyeux, Armand Perret-Liaudet, Roger Later, and Anne-Gaëlle Biacabe
- Subjects
Neurological signs ,Male ,Pathology ,medicine.medical_specialty ,Time Factors ,Tyrosine 3-Monooxygenase ,Blotting, Western ,Disease ,Electroencephalography ,Sensitivity and Specificity ,Creutzfeldt-Jakob Syndrome ,Disease course ,Cerebrospinal fluid ,Reference Values ,mental disorders ,medicine ,Humans ,14-3-3 protein ,CSF albumin ,Aged ,medicine.diagnostic_test ,business.industry ,Sporadic Creutzfeldt-Jakob disease ,Middle Aged ,Prognosis ,nervous system diseases ,Neurology ,14-3-3 Proteins ,Female ,Neurology (clinical) ,business - Abstract
Diagnosis of Creutzfeldt-Jakob Disease (CJD) is based on neurological signs associated with characteristic electroencephalographic activity or detection of 14-3-3 protein in cerebrospinal fluid. However, the time course of 14-3-3 protein release during sporadic CJD is unknown. We report two observations in which the level of the detected 14-3-3 protein increased significantly with time. These preliminary cases suggest that there may be an increased release of 14-3-3 protein during the course of CJD as already proven for iatrogenic CJD.
- Published
- 2002